A European Medicines Agency committee, on Thursday, accepted the use of an artificial intelligence (AI) tool called AIM-NASH ...

The role of AI in supply chain management proved to be the focal issue at the recent 2025 Clinical Trial Supply Europe ...

Generative AI can support decisions about a clinical trial’s target patient population by enhancing subgroup discovery, refining trial eligibility criteria, and helping remove patients who are ...

Unveiling the power of AI in patient subgroups SOMS' AI-driven subgroup analysis is transforming clinical trials through real-time data processing and continuous tracking of patient subgroups.

Clinical trials are becoming increasingly complex ... Join us for this valuable discussion for key insights into how AI is transforming workflows to help address today’s top data challenges.

The European Medicines Agency (EMA) gave its approval to an artificial intelligence diagnostic tool for the first time on ...

Artificial intelligence (AI) is the new frontier, and it would be remiss not to leverage it to enhance DEI in clinical trials. AI-powered tools can be utilised in several ways; for example, to assist ...

In a recent interview with Fierce Biotech's Chris Hayden, Fortrea's Chief Technology and Data Officer Alaric Jackson discussed the growing role of AI in clinical trials. Jackson described how AI ...

Powered by Real-World Expertise: Cliniphai has built deep operational experience across clinical studies and is working with trusted partners that have spent decades ensuring linguistic accuracy in ...

A major overhaul and consolidation of EU clinical trial regulations is paving the way to faster approvals, greater international coordination, and resilience to drug shortages, according to ...